Effect of Silymarin and Harpagoside on Inflammation Reaction of BEAS-2B Cells, on Ciliary Beat Frequency (CBF) of Trachea Explants and on Mucociliary Clearance (MCC)

Abstract

Silymarin and harpagoside are derived from drugs which are used for their protective effects against hepatotoxicity and inflammatory processes. Both are now investigated with respect to the respiratory tract. They were able to reduce the release of the inflammatory cytokine RANTES (regulated on activation, normal T cells expressed and secreted) from BEAS-2B cells in a concentration-dependent manner when stimulated by a cytokine mix (10 ng/mL of TNF-α and IFN-γ). This effect was not due to a possible toxic effect (control experiments using LDH release as a marker). Silymarin but not harpagoside was able to increase ciliary beat frequency. Effects were comparable to positive controls (isoprenaline and salbutamol). Silymarin also increases mucociliary clearance. In conclusion, silymarin should be further investigated for its clinical use in distinct respiratory diseases.

Key words

silymarin - harpagoside - respiratory disease - cytokine RANTES - ciliary beat frequency - mucociliary clearance

References

• 1 Zariwala M A, Knowles M R, Omran H. Genetic defects in ciliary structure and function.  Annu Rev Physiol. 2007;  69 423-450
• 2 Horváth J, Fliegauf M, Olbrich H, Kispert A, King S M, Mitchison H, Zariwala M A, Knowles M R, Sudbrak R, Fekete G, Neesen J, Reinhardt R, Omran H. Identification and analysis of axonemal dynein light chain 1 in primary ciliary dyskinesia patients.  Am J Respir Cell Mol Biol. 2005;  33 41-47
• 3 Palmqvist C, Wardlaw A J, Bradding P. Chemokines and their receptors as potential targets for the treatment of asthma.  Br J Pharmacol. 2007;  151 725-736
• 4 Humbert M, Ying S, Corrigan C, Menz G, Barkans J, Pfister R, Meng Q, Van Damme J, Odenakker G, Durham S R, Kay A B. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3.  Am J Respir Cell Mol Biol. 1997;  16 1-8
• 5 Nagase H, Miyamasu M, Yamaguchi M, Fujisawa T, Kawasaki H, Ohta K, Yamamoto K, Morita Y, Hirai K. Regulation of chemokine receptor expression in eosinophils.  Int Arch Allergy Immunol. 2001;  125 29-32
• 6 Busse W W, Lemanske R F. Asthma.  N Engl J Med. 2001;  344 350-362
• 7 Shaker E, Mahmoud H, Mnaa S. Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage.  Food Chem Toxicol. 2010;  48 803-806
• 8 Morishima C, Shuhart M C, Wang C C, Paschal D M, Apodaca M C, Liu Y, Sloan D D, Graf T N, Oberlies N H, Lee D Y, Jerome K R, Polyak S J. Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection.  Gastroenterology. 2010;  138 671-681
• 9 Matsuda T, Ferreri K, Todorov I, Kuroda Y, Smith C V, Kandeel F, Mullen Y. Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways.  Endocrinology. 2005;  146 175-185
• 10 Baghdikian B, Lanhers M C, Fleurentin J, Ollivier E, Maillard C, Balansard G, Mortier F. An analytical study, anti-inflammatory and analgesic effects of Harpagophytum procumbens and Harpagophytum zeyheri.  Planta Med. 1997;  63 171-176
• 11 Loew D, Möllerfeld J, Schrödter A, Puttkammer S, Kaszkin M. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo.  Clin Pharmacol Ther. 2001;  69 356-364
• 12 Reddel R R, Ke Y, Gerwin B I, McMenamin M G, Lechner J F, Su R T, Brash D E, Park J B, Rhim J S, Harris C C. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes.  Cancer Res. 1988;  48 1904-1909
• 13 Mercke U, Hakansson C H, Toremalm N G. The influence of temperature on mucociliary activity. Temperature range 20 degrees C–40 degrees C.  Acta Otolaryngol. 1974;  78 444-450
• 14 Grubb B R, Jones J H, Boucher R C. Mucociliary transport determined by in vivo microdialysis in the airway of normal and CF mice.  Am J Physiol Lung Cell Mol Physiol. 2004;  286 L588-L595
• 15 Lopez-Vidriero M T, Jacobs M, Clarke S W. The effect of isoprenaline on the ciliary activity of an in vitro preparation of rat trachea.  Eur J Pharmacol. 1985;  112 429-432
• 16 Frohock J I, Wijkstrom-Frei C, Salathe M. Effects of albuterol enantiomers on ciliary beat frequency in ovine tracheal epithelial cells.  J Appl Physiol. 2002;  92 2396-2402
• 17 Devalia J L, Sapsford R J, Rusznak C, Toumbis M J, Davies R J. The effects of salmeterol and salbutamol on ciliary beat frequency of cultured human bronchial epithelial cells, in vitro.  Pulm Pharmacol. 1992;  5 257-263
• 18 Stellato C, Beck L A, Gorgone G A, Proud D, Schall T J, Ono S J, Lichtenstein L M, Schleimer R P. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids.  J Immunol. 1995;  155 410-418
• 19 Wingett D, Forcier K, Nielson C P. Glucocorticoid-mediated inhibition of RANTES expression in human T lymphocytes.  FEBS Lett. 1996;  398 308-311
• 20 Wang J H, Devalia J, Xia C, Sapsford R J, Davies R J. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids.  Am J Respir Cell Mol Biol. 1996;  14 27-35
• 21 Fujisawa T, Kato Y, Atsuta J, Terada A, Iguchi K, Kamiya H, Yamada H, Nakajima T, Miyamasu M, Hirai K. Chemokine production by the BEAS-2B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by TH2- and TH1-derived cytokines.  J Allergy Clin Immunol. 2000;  105 126-133
• 22 Hallsworth M P, Twort C H, Lee T H, Hirst S J. Beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells.  Br J Pharmacol. 2001;  132 729-741
• 23 Li P, Zhang Y, Xiao L, Jin X, Yang K. Simultaneous determination of harpagoside and cinnamic acid in rat plasma by high-performance liquid chromatography: application to a pharmacokinetic study.  Anal Bioanal Chem. 2007;  389 2259-2264